A counterfeit component and an order that never arrives are different supply-chain failures. Both can disrupt manufacturing, but they call for different evidence and controls. Confusing them makes it harder to understand what a supplier-risk process actually needs to address.
Check the trend rather than assume it
In his Fireside Chat, Dr. Diganta Das describes reviewing counterfeit reports during the pandemic-era component shortage. He explains that the reported pattern did not simply match an expectation of a large increase across every component category.
A plausible explanation for risk is not the same as a measured trend. Reports need to be interpreted in their context, including the time period, component categories and types of incidents being counted. Those distinctions affect what the data can support.
Different components present different opportunities
Das distinguishes reused or remarked parts from devices manufactured to imitate an expected component. He also points out that manufacturing a sophisticated processor from scratch requires a very different level of capability than producing a simpler device.
A shortage of one product category therefore does not imply that every counterfeiting route is equally feasible. The inspection strategy should reflect the component, the procurement channel and the suspect condition.
Non-delivery is not an imaging problem
The discussion separately identifies payment demands, shipments containing the wrong items and orders that are not fulfilled. X-ray inspection can examine received hardware, but it cannot inspect a part that never arrives. Supplier evaluation and transaction controls address that earlier stage.
Assign each control a defined task
Purchasing checks, documentation review, internal imaging and electrical tests supply different types of evidence. A risk-based process connects them instead of treating one method as a universal answer. For received components, X-ray examination can support a defined investigation of internal structure.